Qi Chen1, Xiaoyi Wang1, Jingjing Min2, Lin Wang3, Lijun Mou4. 1. Department of Nephrology, The First People's Hospital of Huzhou, 313000, Huzhou, Zhejiang, People's Republic of China. 2. Department of Neurology, The First People's Hospital of Huzhou, 313000, Huzhou, Zhejiang, People's Republic of China. 3. Guangzhou Kingmed Diagnostic Laboratory Ltd, 510320, Guangzhou, Guangzhou, Guangdong, People's Republic of China. 4. Division of Nephrology, Second Affiliated Hospital of Zhejiang University School of Medicine, No.88, Jiefang Road, Shangcheng District, Hangzhou, Zhejiang, 310009, People's Republic of China. moulj511@zju.edu.cn.
Abstract
BACKGROUND: Gitelman syndrome (GS) is an autosomal recessive inherited salt-losing tubulopathy (SLT). Here, we describe, for the first time, a case of GS without Gitelman-like features and with concomitant kidney stones, cysts and diabetic nephropathy (DN). CASE PRESENTATION: We described a male patient had a 19-year history of recurrent fatigue. From childhood, he had polydipsia and polyuria, paroxysmal tetany and palpitation. Serum biochemistry revealed chronic hypokalemia, metabolic alkalosis, normomagnesemia, mildly elevated Cr. Concomitant 24 h urine collection showed inappropriate renal potassium wasting, borderline hypercalciuria, moderate proteinuria consisting of major glomerular. Ultrasound of urinary tract showed bilateral and multiple kidney stones and cysts. Whole exome sequencing (WES) identified compound heterozygous mutations of SLC12A3. The unusual association of SLTs and glomerular proteinuria prompted us to perform a renal biopsy. Renal pathology showed renal involvement consistent with GS and early stage of diabetic nephropathy (DN). After treatment with KCl, magnesium oxide, perindopril and acarbose, the patient had been cured. The fatigue didn't relapse. CONCLUSION: GS had high variability of phenotype, GS may have no Gitelman-like features, kidney stones are not the exclusion criteria of GS. Renal biopsy should be warranted for GS patients with moderate to massive glomerular proteinuria.
BACKGROUND: Gitelman syndrome (GS) is an autosomal recessive inherited salt-losing tubulopathy (SLT). Here, we describe, for the first time, a case of GS without Gitelman-like features and with concomitant kidney stones, cysts and diabetic nephropathy (DN). CASE PRESENTATION: We described a male patient had a 19-year history of recurrent fatigue. From childhood, he had polydipsia and polyuria, paroxysmal tetany and palpitation. Serum biochemistry revealed chronic hypokalemia, metabolic alkalosis, normomagnesemia, mildly elevated Cr. Concomitant 24 h urine collection showed inappropriate renal potassium wasting, borderline hypercalciuria, moderate proteinuria consisting of major glomerular. Ultrasound of urinary tract showed bilateral and multiple kidney stones and cysts. Whole exome sequencing (WES) identified compound heterozygous mutations of SLC12A3. The unusual association of SLTs and glomerular proteinuria prompted us to perform a renal biopsy. Renal pathology showed renal involvement consistent with GS and early stage of diabetic nephropathy (DN). After treatment with KCl, magnesium oxide, perindopril and acarbose, the patient had been cured. The fatigue didn't relapse. CONCLUSION: GS had high variability of phenotype, GS may have no Gitelman-like features, kidney stones are not the exclusion criteria of GS. Renal biopsy should be warranted for GS patients with moderate to massive glomerular proteinuria.
Entities:
Keywords:
Case report; Diabetic nephropathy; Gitelman syndrome; Kidney stones
Authors: Anne Blanchard; Detlef Bockenhauer; Davide Bolignano; Lorenzo A Calò; Etienne Cosyns; Olivier Devuyst; David H Ellison; Fiona E Karet Frankl; Nine V A M Knoers; Martin Konrad; Shih-Hua Lin; Rosa Vargas-Poussou Journal: Kidney Int Date: 2017-01 Impact factor: 10.612
Authors: Eduardo De la Cruz-Cano; Cristina Del C Jiménez-González; Vicente Morales-García; Conny Pineda-Pérez; Juan G Tejas-Juárez; Francisco J Rendón-Gandarilla; Silvia Jiménez-Morales; José A Díaz-Gandarilla Journal: BMC Nephrol Date: 2019-10-28 Impact factor: 2.388